Background and purpose Neurological manifestations in coronavirus disease (COVID)‐
2019 may adversely affect clinical outcomes. Severe COVID‐19 and uremia are risk factors …

Objective Many neurological manifestations are associated with COVID‐19, including a
distinct form of encephalopathy related to cytokine storm, the acute systemic inflammatory …

BACKGROUND: Recent findings indicated that SARS-CoV-2 related neurological
manifestations involve cytokine release syndrome along with endothelial activation, blood …

Background: A growing number of reports suggest that infection with SARS-CoV-2 often
leads to neurological involvement; however, data on the incidence and severity are limited …

The new coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), can trigger a hyperinflammatory state characterized …

Background Neurological manifestations are common in patients with coronavirus disease
2019 (COVID-19), but little is known about pathophysiological mechanisms. In this single …

Objective Coronavirus disease (COVID-19) has been associated with a large variety of
neurologic disorders. However, the mechanisms underlying these neurologic complications …

Aim The aim of this paper is to describe the clinical features of COVID‐19‐related
encephalopathy and their metabolic correlates using brain 2‐desoxy‐2‐fluoro‐D‐glucose …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the
coronavirus disease 2019 (COVID-19) pandemic. In addition to severe respiratory …

Patients with coronavirus disease 2019 (COVID‐19) can present with distinct neurological
manifestations. This study shows that inflammatory neurological diseases were associated …